Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS
Open Access
- 1 July 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 125 (1) , 117-122
- https://doi.org/10.1046/j.1365-2249.2001.01560.x
Abstract
CVI is a primary immunodeficiency characterized by a failure of B cell differentiation associated with an array of T cell defects, such as enhanced T cell apoptosis. In this study we investigated the mechanisms underlying CVI enhanced T cell death. We analysed both the expression of Fas using flow cytometry techniques and the expression of FasL mRNA using RT‐PCR in CVI T cells. We could not find any significant differences between CVI and normal subjects with regard to Fas expression, although there was a subgroup of CVI patients with very high Fas expression which was accompanied by an up‐regulation of FasL mRNA. However, attemps to induce Fas‐mediated apoptosis in these high Fas expressing cells, as evaluated by propidium iodide staining and APO2·7 staining, were unsuccessful. We also investigated intracellular levels of Bcl‐2, bcl‐xl and bax in CD4+ and CD8+ CVI T cells, as well as the bax/Bcl‐2 ratio, using flow cytometry techniques but could not detect any differences between CVI and normal subjects. Finally we analysed TNF‐RI and TNF‐RII mRNA expression in CD4+ and CD8+ CVI T cells using semiquantitative RT‐PCR and found a significant increase in expression of both TNF‐Rs in CD4+ T cells from CVI patients. Our data suggest that the increased expression of both TNF‐Rs on T cells may be one of the mechanisms responsible for the accelerated T cell apoptosis in CVI.Keywords
This publication has 31 references indexed in Scilit:
- Fas and FasL in the homeostatic regulation of immune responsesPublished by Elsevier ,2001
- Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosisClinical and Experimental Immunology, 1997
- A Peptide Sequence from Bax That Converts Bcl-2 into an Activator of ApoptosisPublished by Elsevier ,1996
- Interleukin‐2 receptor common γ‐chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti‐apoptotic (bcl‐2, bcl‐xL) but not pro‐apoptotic (bax, bcl‐xS) gene expressionEuropean Journal of Immunology, 1996
- Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiencyEuropean Journal of Immunology, 1996
- Induction of apoptosis in mature T cells by tumour necrosis factorNature, 1995
- Fas and Fas ligand: lpr and gld mutationsImmunology Today, 1995
- Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID)Clinical and Experimental Immunology, 1992
- DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagementCellular Immunology, 1992
- Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2Clinical Immunology and Immunopathology, 1990